Agree!
MMR is also in the final stages of negotiating an agreement with a large investment fund specializing in financing the enforcement and licensing of global intellectual property rights using non-dilutive structured partnerships. This would maximize MMR's ability to exploit its global health IT patent portfolio and also the biotech assets it acquired through a reverse merger with Favrille, Inc. in January 2009.
According to Robert H. Lorsch, MMRGlobal CEO, "With patents in 13 countries, a joint venture agreement in China, and Meaningful Use Stage 2 being implemented here in the U.S., MMR is uniquely positioned to be the go anywhere global brand. Over the past several months, MMR has been contacted by numerous hedge funds and other investors that specialize in the exploitation of patents and intellectual property. These funds form structured partnerships that participate in the flow of royalties from a group or bucket of patents in different countries. With all of North America at our fingertips, we believe now is the time to avail MMR to that type of strategic partnership."
The Canadian patent is directed toward methods for providing users with the ability to access and collect health records and covers the exchange of protected health information to and from patients, doctors, pharmacies, insurance providers and other healthcare professionals in forms including, but not limited to, email, text, phone, facsimile and web-based portals.
Looks like a lot of people see the value of the patents!!
News 
Market Data 
Discover 
